{"filings":[{"id":861916,"accession_number":"0001193125-26-257531","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2026-06-04T20:31:12+00:00","items":["5.02"],"status":"ready","headline":"Innospec appoints Shelley Bausch to Board and Audit Committee effective July 1, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board expanded from 7 to 8 directors; Bausch appointed as Class II director through 2027 annual meeting.","Bausch will serve on Audit Committee; receives standard non-employee director compensation.","Annual cash retainer of $100,000 + $5,000 audit committee member retainer, paid quarterly.","Eligible for annual equity grant of $125,000 (February grant, RSUs vesting in 3 years)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":49486,"accession_number":"0001193125-26-220407","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2026-05-13T10:00:29+00:00","items":["5.07"],"status":"ready","headline":"Innospec shareholders re-elect two Class I directors, approve executive compensation","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders re-elected Elizabeth K. Arnold (19.3M for) and Claudia P. Poccia (19.7M for) as Class I directors.","Advisory vote on executive compensation approved: 20.2M for, 0.86M against, 0.03M abstain.","Ratification of independent auditor approved: 22.6M for, 14.7K against, 4.3K abstain.","Annual meeting turnout: 22.7M shares present (91% of 24.9M outstanding)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":90949,"accession_number":"0001193125-26-213160","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2026-05-08T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Innospec Q1 revenue $453.2M (+3% YoY); adjusted EPS $1.05 vs $1.42; dividend raised 10% to $0.92","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP EPS $1.22, net income $30.4M; adjusted non-GAAP EPS $1.05 (both down YoY).","Revenue grew 3% to $453.2M; Fuel Specialties strength offset winter storm impacts in other segments.","Semi-annual dividend increased 10% to $0.92/share, payable May 29 to holders of record May 19.","New $75M share repurchase authorization replaces existing $50M plan; $6.2M repurchased in Q1.","Net cash $289.1M; operating cash flow $17.6M, capital expenditures $8.6M."],"consensus_eps_estimate":1.0557,"consensus_eps_actual":1.22,"consensus_revenue_estimate":null,"consensus_revenue_actual":453200000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":100813,"accession_number":"0001193125-26-055921","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2026-02-18T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Innospec reports Q4 GAAP EPS $1.91, adjusted EPS $1.50; revenue $455.6M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $47.4M ($1.91 diluted) vs net loss $70.4M ($2.80 loss) last year, which included UK pension buyout.","Adjusted non-GAAP EPS $1.50 vs $1.41 a year ago; Adjusted EBITDA $55.7M vs $56.6M.","Revenue decreased 2% to $455.6M from $466.8M; Fuel Specialties operating income grew 7% with improved margins.","Cash from operations $61.4M; net cash at year-end $292.5M; capital expenditures $20.5M.","Performance Chemicals and Oilfield Services showing sequentially improving results."],"consensus_eps_estimate":1.2648,"consensus_eps_actual":4.67,"consensus_revenue_estimate":null,"consensus_revenue_actual":1778000000.0,"consensus_period":"2025-FY","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117113,"accession_number":"0001193125-25-265585","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Innospec Q3 EPS $0.52 GAAP ($1.12 adj), down from $1.33; impairments of $42.9M; dividend +10%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $441.9M flat YoY; net income $12.9M vs $33.4M; adjusted EBITDA $44.2M vs $50.5M.","GAAP EPS $0.52; adjusted non-GAAP EPS $1.12, down from $1.35; special items net $24.4M charge.","Impairments and restructuring of $42.9M in oilfield production and US stimulation businesses, offset by $18.5M contingent consideration reduction.","Semi-annual dividend raised 10% to $0.87/share ($1.71 annual), payable Nov 26 to holders of record Nov 18.","Operating cash flow $39.3M; net cash $270.8M; $10.7M share repurchases in quarter."],"consensus_eps_estimate":1.0812,"consensus_eps_actual":2.76,"consensus_revenue_estimate":null,"consensus_revenue_actual":1322400000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133563,"accession_number":"0001193125-25-173932","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2025-08-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Innospec Q2 2025: Revenue $439.7M (+1% YoY); GAAP EPS $0.94, adjusted EPS $1.26, net cash $266.6M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $439.7M (+1% YoY); GAAP net income $23.5M ($0.94 EPS) vs $31.2M ($1.24 EPS) last year.","Adjusted non-GAAP EPS $1.26 vs $1.39 a year ago; adjusted EBITDA $49.1M vs $54.1M.","Fuel Specialties operating income grew strongly, offsetting weaker results in other segments.","Net cash $266.6M, debt-free; $8.2M share repurchases and $0.84 semi-annual dividend paid in Q2.","Company expects sequential gross margin and operating income improvement in H2 2025."],"consensus_eps_estimate":1.292,"consensus_eps_actual":2.24,"consensus_revenue_estimate":null,"consensus_revenue_actual":880500000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150240,"accession_number":"0001193125-25-119308","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2025-05-14T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Innospec shareholders elect three Class III directors and approve advisory proposals at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["David F. Landless, Lawrence J. Padfield, and Patrick S. Williams elected with 21.7M–22.4M votes for each.","Advisory vote on executive compensation passed: 22.0M for, 0.8M against, 0.02M abstain.","Ratification of independent auditor (Ernst & Young) approved: 23.7M for, 16k against, 30k abstain.","Broker non-votes of 958,863 recorded for director election and say-on-pay proposals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150239,"accession_number":"0001193125-25-116398","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2025-05-09T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Innospec Q1 revenue $440.8M (-12% YoY); GAAP EPS $1.31, adj EPS $1.42; dividend +10%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $32.8M ($1.31 diluted EPS) vs $41.4M ($1.65) a year ago; adjusted EPS $1.42 vs $1.75.","Revenue $440.8M, down 12% from $500.2M; Fuels Specialties growth offset by declines in Performance Chemicals and Oilfield Services.","Adjusted EBITDA $54.0M vs $64.0M in Q1 2024; cash from ops $28.3M.","Semi-annual dividend raised 10% to $0.84/share; payable May 30, record May 20. $50M buyback announced; 34,100 shares repurchased in Q1.","Net cash $299.8M; debt-free balance sheet."],"consensus_eps_estimate":null,"consensus_eps_actual":1.31,"consensus_revenue_estimate":null,"consensus_revenue_actual":440800000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169249,"accession_number":"0001193125-25-051396","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2025-03-11T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Innospec board approves $50M buyback over 3 years; net cash $289M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board authorized repurchase of up to $50M in common stock over three years starting March 10, 2025.","Prior $50M share repurchase program expired in Q1 2025; this renews the authorization.","CEO cites $289M net cash, flexibility for M&A, organic investment, dividend growth, and buybacks.","Purchases may be made at management's discretion via open market or accelerated repurchases."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169248,"accession_number":"0001193125-25-029065","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2025-02-19T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Innospec Q4 GAAP loss $2.80 on $155.6M pension charge; adjusted EPS $1.41","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net loss of $70.4M ($2.80 per share) driven by $155.6M non-cash UK pension buyout settlement charge.","Adjusted non-GAAP EPS of $1.41 vs $1.84 a year ago; revenue $466.8M (-6% YoY).","Performance Chemicals operating income +14%; Fuel Specialties +7%; Oilfield Services continued weakness in Latin America.","Generated $25.7M cash from operations; net cash $289.2M at year-end."],"consensus_eps_estimate":null,"consensus_eps_actual":1.42,"consensus_revenue_estimate":null,"consensus_revenue_actual":1845400000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186286,"accession_number":"0001193125-24-251643","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2024-11-06T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Innospec Q3 revenue $443M (-4% YoY), EPS $1.33, dividend raised 10% to $1.55 annual","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $443.4M, down 4% YoY from $464.1M; net income $33.4M vs $39.2M; GAAP EPS $1.33, adjusted $1.35.","Performance Chemicals and Fuel Specialties operating income up double digits with margin expansion.","Oilfield Services results impacted by lower production chemical activity, as expected.","Cash from operations $73.5M; net cash $303.8M at quarter end.","Semi-annual dividend $0.79/share; annual dividend raised 10% to $1.55; payable Nov 26 to holders of record Nov 18."],"consensus_eps_estimate":null,"consensus_eps_actual":4.22,"consensus_revenue_estimate":null,"consensus_revenue_actual":1378600000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202907,"accession_number":"0001193125-24-195351","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2024-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Innospec Q2: rev $435M (-9% YoY), GAAP EPS $1.24, adj EPS $1.39, net cash $240M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $435M (-9% YoY); net income $31.2M ($1.24 diluted EPS) vs $28.9M ($1.16) prior year.","Adjusted non-GAAP EPS $1.39 vs $1.28; adjusted EBITDA $54.1M (up from $47.4M).","Performance Chemicals operating income more than doubled; Fuel Specialties operating income up double digits.","Oilfield Services impacted by lower production chemical activity as expected.","Quarter-end net cash $240.2M; paid semi-annual dividend $0.76/share."],"consensus_eps_estimate":null,"consensus_eps_actual":2.89,"consensus_revenue_estimate":null,"consensus_revenue_actual":935200000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219109,"accession_number":"0001193125-24-143279","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2024-05-21T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Innospec extends $250M multicurrency revolver maturity to May 2028","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["May 16, 2024: lenders approved extension of $250M revolving facility from May 2027 to May 31, 2028.","Extension effective May 20, 2024; company paid customary extension fee.","No other terms of the credit agreement were modified."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219108,"accession_number":"0001193125-24-137665","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2024-05-14T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Innospec shareholders elect directors, approve say-on-pay and auditor at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Election of Milton C. Blackmore with 22,508,064 for, 578,796 withheld.","Election of Leslie J. Parrette with 20,473,042 for, 2,613,818 withheld.","Advisory vote on exec compensation passed with 22,720,369 for, 319,903 withheld, 46,587 abstain.","Ratification of independent auditor passed with 23,744,512 for, 19,767 withheld, 4,908 abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219107,"accession_number":"0001193125-24-135679","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2024-05-10T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Innospec Q1 revenue $500.2M (-2%); GAAP EPS $1.65, adjusted $1.75; dividend up 10%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP EPS $1.65 vs $1.33; adjusted non-GAAP EPS $1.75 vs $1.38; net income $41.4M vs $33.2M.","Revenue $500.2M, down 2% from $509.6M YoY; Performance Chemicals drove 23% operating income growth.","Cash from operations $80.6M; net cash $270.1M; capital expenditures $14.3M.","Semi-annual dividend raised 10% to $0.76/share, payable May 31 to holders of record May 20."],"consensus_eps_estimate":null,"consensus_eps_actual":1.65,"consensus_revenue_estimate":null,"consensus_revenue_actual":500200000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219106,"accession_number":"0001193125-24-085374","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2024-04-03T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Innospec EVP & COO Philip Boon to retire effective March 31, 2025; will serve as consultant","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Philip Boon, Executive Vice President and COO, notified Innospec of his decision to retire effective March 31, 2025.","After retirement, Boon will provide support to the company on a consultancy basis, on terms to be agreed.","The departure is planned with a one-year notice period; no immediate impact on operations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":238989,"accession_number":"0001193125-24-034787","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2024-02-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Innospec Q4 net income up 48% to $37.8M; adjusted EPS $1.84 beats prior year $1.20","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $494.7M (-3% YoY); net income $37.8M ($1.51 diluted) vs $25.5M ($1.02) last year.","Adjusted non-GAAP EPS $1.84 vs $1.20; EBITDA $54.0M vs $54.3M.","Cash from operations $72.4M; net cash $203.7M at year-end; paid semi-annual dividend 72¢/share.","Completed acquisition of QGP Quimica Geral, a Brazil-based specialty chemicals company."],"consensus_eps_estimate":null,"consensus_eps_actual":5.56,"consensus_revenue_estimate":null,"consensus_revenue_actual":1948800000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":256479,"accession_number":"0001193125-23-292707","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2023-12-11T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Innospec completes acquisition of Brazilian specialty chemicals company QGP Química Geral","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired QGP, a Brazilian specialty chemicals firm with 300 employees, for undisclosed terms.","QGP adds surfactant and specialty chemistries to Innospec's Performance Chemicals segment.","Deal provides manufacturing and product development base in South America, a key global market.","CEO says Innospec retains a debt-free balance sheet and remains well-positioned for further M&A and shareholder returns."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":256478,"accession_number":"0001193125-23-272887","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2023-11-08T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Innospec Q3 revenue down 10% to $464.1M; EPS $1.57; annual dividend increased 10%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $464.1M vs $513.0M last year, down 10%; net income $39.2M ($1.57 diluted EPS).","Adjusted non-GAAP EPS $1.59 vs $1.74 last year; EBITDA $56.5M vs $59.2M.","Operating cash flow $58.1M; net cash improved to $207.2M at quarter end.","Semi-annual dividend $0.72/shr payable Nov 27, 2023; full-year dividend $1.41, up 10% from 2022.","Performance Chemicals showed sequential improvement; Oilfield Services and Fuel Specialties remained strong."],"consensus_eps_estimate":null,"consensus_eps_actual":4.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":1454100000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":273873,"accession_number":"0001193125-23-206322","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2023-08-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Innospec Q2 revenue up 3% to $480.4M; net income falls to $28.9M on $8M Brazil exit charge","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP EPS $1.16 vs $1.29 a year ago; adjusted non-GAAP EPS $1.28 vs $1.58.","Revenue $480.4M (+3% YoY); Oilfield Services results cited as exceptional.","EBITDA $46.2M, down from $52.9M; cash from operations $55.0M.","Net cash improved to $165.9M; paid $0.69 semi-annual dividend per share.","Special $8.0M charge to exit Brazil trading relationship reduced EPS by $0.21."],"consensus_eps_estimate":null,"consensus_eps_actual":2.48,"consensus_revenue_estimate":null,"consensus_revenue_actual":990000000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":290964,"accession_number":"0001193125-23-159041","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2023-06-01T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Innospec closes new $250M multicurrency revolving credit facility, replacing 2019 bank facility","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Four-year unsecured facility matures May 30, 2027, with option to extend one year at Company's discretion.","Accordion feature permits increasing total commitments by up to $125M; lenders include Barclays, U.S. Bank, Wells Fargo, and new JP Morgan.","Initial interest margin increased to 1.25% over Term SOFR (USD) and SONIA (GBP), replacing LIBOR-based pricing.","Proceeds for general corporate purposes, working capital, and future acquisitions; backed by Company and subsidiary guarantees."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":290963,"accession_number":"0001193125-23-145129","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2023-05-15T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Innospec director Robert Paller will not stand for re-election at 2024 Annual Meeting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Robert Paller informed Innospec on May 8, 2023 of his decision not to stand for re-election.","Mr. Paller will remain on the Board until the 2024 Annual Meeting.","Decision not the result of any disagreement with the company or its operations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":290962,"accession_number":"0001193125-23-138364","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2023-05-08T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Innospec shareholders elect two Class I directors and approve say-on-pay frequency of 1 year","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Claudia P. Poccia elected with 20,015,816 for (2,989,917 withheld); Elizabeth K. Arnold with 22,406,421 for (599,312 withheld).","Advisory vote on executive compensation frequency: 1 year received 21,639,226 votes (87% of cast); board sets annual say-on-pay.","Executive compensation advisory approved with 22,174,236 for vs 817,808 against (96% approval).","Ratification of PricewaterhouseCoopers as auditor approved with 23,854,177 for vs 23,472 against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":290961,"accession_number":"0001193125-23-134590","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2023-05-03T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Innospec reports Q1 revenue up 8% to $509.6M; GAAP EPS $1.33, adjusted EPS $1.38","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $509.6M (+8% YoY) driven by strong Oilfield Services growth.","GAAP EPS $1.33 vs $1.46; adjusted non-GAAP EPS $1.38 vs $1.53.","EBITDA of $53.9M compared to $59.0M in prior-year quarter.","Semi-annual dividend increased 10% to $0.69/share, payable May 31 to holders of record May 22.","Operating cash flow $21.8M; net cash at quarter end $147.5M."],"consensus_eps_estimate":null,"consensus_eps_actual":1.33,"consensus_revenue_estimate":null,"consensus_revenue_actual":509600000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":311800,"accession_number":"0001193125-23-044076","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2023-02-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Innospec Q4 revenue up 24% to $510.7M; adjusted EPS $1.20 vs $1.30 YoY; net cash $147.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $510.7M (+24% YoY); net income $25.5M ($1.02 diluted EPS) vs $23.9M ($0.96) last year.","Adjusted non-GAAP EPS $1.20, down from $1.30 YoY, impacted by $0.36 higher tax charges.","EBITDA $54.3M vs $44.8M; operating income growth 31% for quarter, 42% for full year.","Generated $78.4M cash from operations; net cash improved to $147.1M from $100.5M at Q3 end.","Paid semi-annual dividend of $0.65/share; repurchased 8,514 shares for $0.7M."],"consensus_eps_estimate":null,"consensus_eps_actual":5.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":1963700000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":330362,"accession_number":"0001193125-22-304078","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2022-12-14T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Innospec posts updated corporate presentation on its website","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Presentation dated December 2022 posted on Investors section of innospec.com.","No financial results or guidance disclosed in the filing.","Item 7.01 Regulation FD disclosure only; no material new information provided."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":330361,"accession_number":"0001193125-22-280623","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2022-11-09T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Innospec Q3 revenue up 36% to $513M; adjusted EPS $1.74 vs $1.15; dividend raised 10%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $513.0M, +36% YoY; net income $38.7M ($1.55 EPS) vs $23.4M ($0.94).","Adjusted non-GAAP EPS $1.74, up from $1.15 in prior-year quarter.","EBITDA $59.2M vs $41.4M; cash from ops $39.8M; net cash $100.5M.","Declared $0.65 semi-annual dividend; annual dividend $1.28, a 10% increase over 2021.","Repurchased 25,000 shares for $2.3M in Q3."],"consensus_eps_estimate":null,"consensus_eps_actual":4.3,"consensus_revenue_estimate":null,"consensus_revenue_actual":1453000000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":347914,"accession_number":"0001193125-22-210456","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2022-08-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Innospec Q2 2022 revenue up 32% to $467.6M; adjusted EPS $1.58 vs $1.30 last year","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP EPS of $1.29 ($32.3M net income) versus $0.90 in Q2 2021.","Adjusted non-GAAP EPS of $1.58; revenue $467.6M, up 32% YoY.","EBITDA of $52.9M compared to $50.6M a year ago.","Cash used in operations $7.5M due to working capital increase; net cash $71.4M at quarter end.","Repurchased 18,700 shares for $1.8M; plans for further Performance Chemicals capacity expansion."],"consensus_eps_estimate":null,"consensus_eps_actual":2.76,"consensus_revenue_estimate":null,"consensus_revenue_actual":940000000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":364469,"accession_number":"0001193125-22-142875","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2022-05-06T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Innospec shareholders elect directors, approve say-on-pay, ratify auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["David F. Landless elected with 22,503,235 votes for; 541,013 withheld.","Lawrence J. Padfield elected with 22,923,266 votes for; 120,982 withheld.","Patrick S. Williams elected with 22,936,258 votes for; 107,990 withheld.","Advisory vote on executive compensation approved: 22,467,964 for, 529,713 against.","Ratification of independent auditor: 23,603,686 for, 18,604 against, 8,992 abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":364468,"accession_number":"0001193125-22-139287","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2022-05-04T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Innospec Q1 revenue up 39% to $472.4M; adjusted EPS $1.53; dividend increased 11%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $472.4M (+39% YoY); net income $36.5M ($1.46 diluted EPS) vs $23.4M ($0.94)","Adjusted non-GAAP EPS $1.53 vs $1.06; EBITDA $59.0M (+43%)","Semi-annual dividend raised 11% to $0.63/share, payable May 26 to holders of record May 17","Repurchased 10,000 shares for $0.9M under board-authorized program","Cash used in operations $29.0M on working capital; net cash $105.6M"],"consensus_eps_estimate":null,"consensus_eps_actual":1.46,"consensus_revenue_estimate":null,"consensus_revenue_actual":472400000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":384165,"accession_number":"0001193125-22-043887","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2022-02-16T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Innospec Q4 revenues up 33% to $413M; GAAP EPS $0.96, adjusted EPS $1.30; announces $50M buyback","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenues $413.2M (+33% YoY); GAAP diluted EPS $0.96, adjusted non-GAAP EPS $1.30.","Record quarterly sales in Performance Chemicals and Fuel Specialties; Oilfield Services sequential growth.","Generated $68.8M cash from operations; net cash position improved to $141.7M at year-end.","Board authorized new $50M share repurchase program; semi-annual dividend of $0.59/share paid.","EBITDA Q4 $44.8M vs $40.2M YoY; full year results also strong."],"consensus_eps_estimate":null,"consensus_eps_actual":3.75,"consensus_revenue_estimate":null,"consensus_revenue_actual":1483400000.0,"consensus_period":"2021-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":402007,"accession_number":"0001193125-21-349506","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2021-12-07T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Innospec appoints Leslie J. Parrette as non-employee director, board expands to eight","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Leslie J. Parrette appointed to Innospec's Board as Class II director, effective Jan 1, 2022.","Board size increased from 7 to 8; Parrette also joins Nominating and Corporate Governance Committee.","Parrette brings experience as former General Counsel of Novelis, 20 years in public company GC roles.","Non-employee director compensation: $90k annual cash retainer, eligible for $90k in equity awards under 2018 LTIP."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":402006,"accession_number":"0001193125-21-317593","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2021-11-03T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Innospec Q3 revenue up 42% to $376.1M; adj. EPS $1.15; annual dividend raised 12% to $1.16","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $376.1M (+42% YoY); net income $23.4M ($0.94 GAAP EPS) vs $12.7M ($0.51) last year.","Adjusted non-GAAP EPS of $1.15, up from $0.71 in Q3 2020.","Performance Chemicals achieved record quarterly sales; Fuel Specialties and Oilfield Services grew strongly.","Semi-annual dividend $0.59 declared ($1.16 annual, 12% increase); payable Nov 24 to holders of record Nov 16.","Net cash $89.2M; cash from ops $2.8M impacted by working capital to offset supply-chain disruption."],"consensus_eps_estimate":null,"consensus_eps_actual":2.78,"consensus_revenue_estimate":null,"consensus_revenue_actual":1070200000.0,"consensus_period":"2021-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":420926,"accession_number":"0001193125-21-235607","cik":1054905,"company_name":"INNOSPEC INC.","ticker":"IOSP","form_type":"8-K","filed_at":"2021-08-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Innospec Q2 revenue up 45% to $354.5M; adjusted EPS $1.30 vs loss year ago","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $354.5M (+45% YoY); net income $22.4M ($0.90 EPS) vs loss of $39.7M a year ago.","Adjusted non-GAAP EPS $1.30 vs loss of $0.18; EBITDA $50.6M vs loss of $19.5M.","Performance Chemicals record sales (op income +47%); Fuel Specialties and Oilfield Services strong sequential improvement.","GAAP and adjusted EPS each benefited $0.16 from AvGas order phasing. Operating cash outflow $1.1M; net cash $94.2M."],"consensus_eps_estimate":null,"consensus_eps_actual":1.84,"consensus_revenue_estimate":null,"consensus_revenue_actual":694100000.0,"consensus_period":"2021-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2023686785.9462872,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}